JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 10 1655-1662
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerber, B. L.
Right arrow Articles by Vanoverschelde, J.-L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerber, B. L.
Right arrow Articles by Vanoverschelde, J.-L. J.

Nitrogen-13-Ammonia and Oxygen-15-Water Estimates of Absolute Myocardial Perfusion in Left Ventricular Ischemic Dysfunction

Bernhard L. Gerber, Bernhard L. Melin, Anne Bol, Daniel Labar, Michel Cogneau, Christian Michel and Jean-Louis J. Vanoverschelde

Division of Cardiology and Positron Emission Tomography Laboratory, University of Louvain Medical School, Brussels and Louvain-la-Neuve, Belgium

Correspondence: For correspondence or reprints contact: Jean-Louis Vanoverschelde, MD, PhD, Division of Cardiology, Climques Universitaires St. Luc, Avenue Hippocrate 10(2881), B–1200 Brussels, Belgium.

ABSTRACT

Measurements of resting myocardial blood flow (MBF)in patients with chronic left ventricular ischemic dysfunction by 15O-water with 13N-ammonia and PET have yielded conflicting results. The aim of this study was to perform a head-to-head comparison of both tracers in the same patient population and to answer the question of whether distinctive tracer properties account for differences in estimates of MBF in chronically dysfunctional myocardiumby both tracers. Methods: A total of 30 patients with chronic dysfunction of the anterior myocardial wall due to significant left anterior descending coronary artery disease underwent PET measurements of absolute MBF in the anteriorwall by use of 15O-waterand 13N-ammonia before coronary revascularization by either coronary artery bypass graft (n = 24) or percutaneous transluminal coronary angioplasty (n =6). Improvement of regional contractile function was assessed by two-dimensional echocardiography at a mean of 7.5 ± 2.1 mo after revascularization. As judged from the changes in anterior myocardial wall motion after revascularization, patients were considered to have either reversibly (n = 16) or persistently (n = 14) dysfunctional myocardium. Estimates of MBF by 15O-water and 13N-ammonia, obtained in every patient before revascularization, were compared among the two patient groups by use of previously validated methods. Results: With 13N-ammonia, resting regional MBF was significantly higher in reversibly as opposed to persistently dysfunctional segments [84 ± 8 versus 48 ± 6ml(min.100g)–1 ,mean ± s.e.m.,p < 0.01]. By contrast, no such difference was found when using 15O-water to measure MBF [74 ± 6 versus 86 ± 9 ml (min.100 g)–1, p = ns]. This was mainly due to the fact that the perfusable tissue fraction (PTF), a fitted parameter of the 15O-water model, was significantly higher in reversibly as opposed to persistently dysfunctional segments (0.63 ± 0.03 versus 0.50 ± 0.03,p < 0.05). As a consequence, the 15O-water perfusable tissue index (P11), which is the ratio of the PTF to the anatomical tissue fraction, was greater in reversibly dysfunctional as opposed to persistently dysfunctional segments (1.07 ± 0.07 versus 0.79 ± 0.05,p < 0.01). Conclusion: This study demonstrates significant differences in MBF estimates between 15O-water and 13N-ammonia in chronically dysfunctional ischemic myocardium. Our results indicate that the 15O-water method yields higher absolute MBF valuesthan the 13N-ammonia approach. Our results also support the use of PT1 as a marker of myocardial tissue viability.

Key Words: myocardial blood flow • PET • myocardial hibernation • nitrogen-13-ammonia • oxygen-15-water




This article has been cited by other articles:


Home page
CirculationHome page
J. B. Selvanayagam, M. Jerosch-Herold, I. Porto, D. Sheridan, A. S.H. Cheng, S. E. Petersen, N. Searle, K. M. Channon, A. P. Banning, and S. Neubauer
Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment
Circulation, November 22, 2005; 112(21): 3289 - 3296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Heusch, R. Schulz, and S. H. Rahimtoola
Myocardial hibernation: a delicate balance
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H984 - H999.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. C. Marshall, P. Powers-Risius, B. W. Reutter, J. P. O'Neil, M. La Belle, R. H. Huesman, and H. F. VanBrocklin
Kinetic Analysis of 18F-Fluorodihydrorotenone as a Deposited Myocardial Flow Tracer: Comparison to 201Tl
J. Nucl. Med., November 1, 2004; 45(11): 1950 - 1959.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Knaapen, R. Boellaard, M. J.W. Gotte, P. A. Dijkmans, L. M.C. van Campen, C. C. de Cock, G. Luurtsema, C. A. Visser, A. A. Lammertsma, and F. C. Visser
Perfusable Tissue Index as a Potential Marker of Fibrosis in Patients with Idiopathic Dilated Cardiomyopathy
J. Nucl. Med., August 1, 2004; 45(8): 1299 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Mazzadi, X. Andre-Fouet, J. Duisit, V. Gebuhrer, N. Costes, P. Chevalier, C. Rodriguez, J.-J. Schott, H. Le Marec, P. Guicheney, et al.
Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1286 - H1293.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G Camici and O. E Rimoldi
Myocardial blood flow in patients with hibernating myocardium
Cardiovasc Res, February 1, 2003; 57(2): 302 - 311.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Iida, Y. Tamura, K. Kitamura, P. M. Bloomfield, S. Eberl, and Y. Ono
Histochemical Correlates of 15O-Water-Perfusable Tissue Fraction in Experimental Canine Studies of Old Myocardial Infarction
J. Nucl. Med., October 1, 2000; 41(10): 1737 - 1745.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.